Form 4: VirnetX CFO Allanson Granted 30,000 Stock Options

Sentiment:

Insider Transaction Disclosure


VirnetX Holding Corp's Chief Financial Officer, Katherine Allanson, was granted 30,000 stock options with an exercise price of $20.22, vesting over four years.

Summary

  • Katherine Allanson, Chief Financial Officer of VirnetX Holding Corp (VHC), was granted 30,000 stock options.
  • The options have an exercise price of $20.22 per share.
  • The grant date and earliest transaction date for these options is November 24, 2025.
  • The options have an expiration date of November 24, 2035.
  • Vesting occurs over four years: 1/4 of the total shares vest on the one-year anniversary of the grant date, and 1/4 vest on each subsequent annual anniversary, contingent on continuous service.
  • All unvested shares underlying the option will vest immediately prior to the consummation of a Change in Control, as defined in the company's plan.
  • The transaction was made pursuant to the Amended and Restated 2013 Equity Incentive Plan.

Sentiment

Score: 6

Explanation: The grant of stock options to a key executive is generally a neutral to slightly positive event, as it aligns management incentives with shareholder interests, though it does not directly impact current financial performance.

Positives

  • The grant of stock options to the Chief Financial Officer aligns management's financial interests with those of shareholders, incentivizing long-term company performance and value creation.
  • The vesting schedule encourages retention of key executive talent over a four-year period.

Future Outlook

The filing details a vesting schedule for the granted stock options, indicating future exercisability contingent on continuous service and potential acceleration upon a Change in Control.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Reference to Equity Incentive PlanThe stock option grant is made pursuant to the company's Amended and Restated 2013 Equity Incentive Plan, which outlines the framework for executive equity compensation.N/AThis indicates that executive compensation is structured within an established and approved corporate governance framework, promoting transparency and adherence to shareholder-approved policies.

Stakeholder Impact

  • Shareholders: The grant of stock options to the Chief Financial Officer aligns her financial interests with those of the shareholders, incentivizing long-term company performance and potentially increasing shareholder value if the stock price rises above the exercise price.
  • Employees (specifically the CFO): The options serve as a form of long-term incentive compensation, encouraging retention and performance.

Next Steps

  • The stock options will vest over a four-year period, with 1/4 vesting annually starting from the one-year anniversary of the grant date (November 24, 2025).
  • The Chief Financial Officer will be able to exercise vested options at the specified exercise price until the expiration date of November 24, 2035.

Key Dates

DateDescription
11/24/2025Date of earliest transaction and grant date for the stock options.
11/24/2025Date when the first 1/4 of the options become exercisable (one-year anniversary of grant date).
11/26/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.
11/24/2035Expiration date of the stock options.

Keywords

VirnetX Holding Corp, VHC, Stock Options, Executive Compensation, CFO, Insider Transaction, Equity Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.